GEN Exclusives

More »

GEN News Highlights

More »
Sep 14, 2009

AbD Serotec and FIND to Develop Heat-Stable Antibodies for Diagnostics to Be Leveraged in Tropical Climates

  • AbD Serotec will collaborate with the Foundation for Innovative New Diagnostics (FIND) on the development of temperature-stable HuCAL-based antibodies as components of parasite diagnostic tests for use in tropical climates. The deal gives FIND commercial rights to these antibodies for in vitro diagnostics.

    AbD Serotec will participate in selling the relevant diagnostic tests in industrialized countries. If successful, the collaboration could be expanded to cover other areas of relevance to the Switzerland-based nonprofit organization.

    FIND is dedicated to the development of new diagnostics for poverty-related diseases such as TB, malaria, and sleeping sickness. The organization points out that most rapid commercial diagnostics are developed for storage and use at 25 to 30 degrees Celsius and are consequently liable to degradation in the higher ambient temperatures of many disease-stricken developing countries. It believes increasing the temperature stability and shelf-life of diagnostic kits could be crucial in the struggle to improve infectious disease control in these areas.

     



Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Megamerger Dealzapoppin Poll

What company not in this week’s M&A headlines do you think will be at the center of a megamerger, acquisition, or partial selloff this year?